Thomas G. Frazier, MD, FACS, is Medical Director of Bryn Mawr Hospital's Comprehensive Breast Center. In this role, Dr. Frazier direct all clinical activities for the Center and provides leadership for programming initiatives. Dr. Frazier is board certified by the American Board of Surgery and also serves as program director for the Breast Surgery Fellowship Program.
Dr. Frazier has a distinguished career in surgical oncology, performing groundbreaking work in the battle against breast cancer. His accomplishments include the first immediate breast reconstruction in the Philadelphia region, allowing women undergoing mastectomy to maintain a natural appearance of the breast. Dr. Frazier has also helped to pioneer several innovative biopsy techniques including sentinel node mapping, reducing the need for more extensive surgery, and ductal lavage and ductoscopy for early detection.
Dr. Frazier is actively involved in clinical research to advance the treatment of women with breast cancer. He serves as a principal investigator to the National Surgical Adjuvant Breast and Bowel Project and has been a top contributor to several landmark research studies, including the use of Tamoxifen as well as a study that compared lumpectomy and radiation to conventional mastectomy.
A graduate of the University of Pennsylvania School of Medicine and of the Hospital's residency program, Dr. Frazier completed a fellowship in Surgical Oncology at The University of Texas - MD Anderson Cancer Center. He is a fellow of the American College of Surgeons and the Philadelphia Academy of Surgery and is a member of numerous societies including the Society of Surgical Oncology, the American Society of Breast Surgeons and the American Society of Breast Disease. He is currently president of the Philadelphia Academy of Surgery. He is published and lectured extensively on breast cancer and has been recognized both locally and nationally for his contributions to the field.
For more information, call 1.866.CALL.MLH.